The National Office of Animal Health has completed its annual review of its Code of Practice for the Promotion of Animal Medicines, and a number of changes will come into effect on 1st July 2011.
One change spells out the way antimicrobial medicines are promoted to farmers, with a firm emphasis on correct use and education.
Advertisers will be required to describe the condition the product is aiming to treat, and to promote an understanding of the treatment of the disease.
The phrase "use medicines responsibly" will always be included in text, making the voluntary strapline introduced in 2009 a formal part of the NOAH Code. As with all promotions to people other than prescribers, farmers will always be reminded to consult their veterinary surgeon.
Advertising text will always state clearly the name of the company and the brand being promoted, and promotion must not be designed to disguise its real nature.
Withdrawal periods for products will be stated, but these must not be unduly prominent and not in a font size greater than the body copy containing recommended dosage and species description.
The changes were proposed by NOAH within its formal response to the Veterinary Medicines Directorate's consultation on the Veterinary Medicines Regulation 2010. The Minister decided in December 2010 to continue to allow the advertising of antimicrobial veterinary products to farmers.
Phil Sketchley, NOAH Chief Executive, said: "Whilst welcoming the Government's decision in December not to further restrict the advertising of animal medicines, we feel that the industry should take a proactive role to ensure the system works properly. We believe it is important for farmers, who are legally responsible for the health and welfare of their animals and the food produced from them, to be aware of the medicines that are available to protect the health of their animals, and at the same time we want them to know that these medicines must be prescribed and used responsibly.
"The issue of antimicrobial resistance is one that affects us all. The way to promote best practice is through education by maintaining all lines of communication between farmers, vets, scientists and animal medicine producers.
"Antibiotics are essential for maintaining the health and welfare of all animals, but like any medicine they need to be used responsibly in order to maintain their effectiveness, and their availability for future generations."
250 mainly menopausal-aged veterinary surgeons and nurses took part in the survey.
Over 80% said the menopause had affected their health. Nearly half said the impact on their mental health had been moderate to severe. Overall, 76% said they were concerned about the impact of the menopause on their health, life and work.
You can read the full survey report here.
The most commonly reported physical symptoms, affecting over three quarters of respondents, were fatigue, irritability and difficultly sleeping. Hot flushes, night sweats and joint pain were also very common. Anxiety was the most common mental health impact, with some individuals experiencing clinical depression and, rarely, suicidal ideation.
Workplace measures said to be helpful included flexible working, help with heavy lifting and provision of fans or air conditioning. Diary management to allow breaks, and openness and understanding amongst colleagues were also valued.
Liz Barton, editor of Veterinary Woman said: “As a predominantly female workforce, we cannot ignore the profound impact the menopause can have both on individuals and veterinary teams. The effects last for an average of seven years and impact a majority of women mid-career. As a profession we have an opportunity to lead this conversation as it’s beginning to open up across the wider media."
Awareness of the impact of menopause was wide-ranging across age categories, but averaged 4.3 out of 10 for those 40 years old and under, and increased to 7.4 out of 10 for those aged 41 and over. Even with relatively high levels of awareness among respondents, 90% said they would like to know more about the impacts from either personal and/or business and human resource perspectives.
SPVS President, Anna Judson (pictured right), said: “Having experienced the effects of the menopause working as a practice owner, I wish I had known more about the impact and that I was not alone in how I was feeling. It’s time to break these taboos, open up the conversation and put in place measures to mitigate the impacts. In so doing, we will not only help individuals to continue to thrive in their careers, but also help practices to retain experienced staff at this challenging time of life."
A free access webinar discussing menopause impacts and how to mitigate is available free at: https://www.veterinarywoman.co.uk/2020/11/menopause-and-the-effect-on-veterinary-professionals-and-teams/
Clare (pictured) who is currently the General Dental Council’s Interim Executive Director for Legal and Governance, will be joining the RCVS as its most senior legal officer at the end of March 2025.
A qualified solicitor, Clare started her practice as a Solicitor Advocate in criminal law, before undertaking roles in regulatory bodies in the healthcare and financial sector.
She joined the General Dental Council in March 2023 and has been in her current role there since March last year.
When she joins the College, Clare will have a dual role.
As Registrar she will be responsible for keeping, maintaining and publishing Registers of veterinary surgeons and veterinary nurses, including oversight of the various mechanisms via which veterinary professionals can join the Register, what they need to do to stay on the Registers, how they may leave or be removed and registration appeals.
As Director of Legal Services, she'll provide leadership and guidance on legal matters within the organisation, including guiding RCVS Council through the development of oral and written legal advice, as well as sitting on committees and working groups in order to ensure the College’s activity is within its legal remit and represents best practice.
RCVS Chief Executive Officer Lizzie Lockett said: “I am sure the RCVS, the professions and the public will benefit from her very relevant experience from senior roles within the General Dental Council, Nursing and Midwifery Council, and Financial Conduct Authority, as well as her private sector legal experience.
“She joins the College at a time of change, with our continued push for new veterinary legislation, the ongoing Competition and Markets Authority investigation of the sector, and a new strategic plan for the College due to be approved this spring.
“The Registrar is the senior legal figure within the organisation, and I am looking forward to Clare contributing her legal expertise on these significant areas of work.
"She joins our very capable legal team, who I am sure will benefit from her leadership, as she will benefit from their sector expertise.”
Clare said: “I am delighted to join the Royal College of Veterinary Surgeons to contribute to the valuable work of safeguarding the interests of the public and animals by supporting veterinary professionals to provide the highest standards of care.”
VetSurgeon.org extends a warm welcome to Clare and wishes her all the very best in her new position.
One small but nevertheless important point is that perhaps a better aim would be to support veterinary professionals in providing just a 'high' standard of care, rather than the 'highest' standards.
It's this constant striving for the 'highest' standards from both a regulatory and clinical perspective that is driving up the cost of veterinary care and making it unaffordable.
This, the company says, makes Simparica Trio the only oral moxidectin that is licensed to treat A.vasorum in dogs in the UK.
Louise Longstaff, National Veterinary Manager at Zoetis UK said: “The last time a product was licensed for the treatment of lungworm in the UK was some time ago, so this is an especially important development.
"Simparica Trio offers a new licensed route of administration for lungworm treatment in dogs, giving vets another option to that which is currently available.
"It enables them to tailor treatment based on their patient’s needs while still prescribing within the cascade.”
Simparica Trio is a chewable monthly tablet for dogs containing sarolaner, moxidectin and pyrantel.
It kills fleas and ticks, treats mites, roundworm and hookworm, prevents and treats lungworm and prevents heartworm disease.
https://www.noahcompendium.co.uk/?id=-485011
Direct Line has revealed the results of a small survey which found that 78% of veterinary surgeons had treated pets for ingesting human medicines in the last year.
100 vets took part in the study, of which 28% reported that they had cases where owners had deliberately given their pet human medication in an attempt to help them. Some vets described incidents of owners believing paracetamol will help conditions like arthritis and limping. In one case an owner gave their cat a quarter of paracetamol every day in an attempt to stop its pain, which instead resulted in the cat dying.
The most common types of medication ingested were:
In total, the veterinary surgeons who took part in the survey reported 243 cases of accidental ingestion of human medicines. The majority (76%) of cases involved dogs. However incidents involving cats, rabbits and guinea pigs were also reported.
Sheila Wills BSc BVetMed CertSAM DipECVIM-CA MRCVS, specialist in internal medicine, has joined Wey Referrals, the Surrey-based multi-disciplinary veterinary referral practice.
Professor John Innes, Referral Director at CVS (of which Wey Referrals is a part) said: "We are delighted to welcome Sheila to our specialist team at Wey Referrals. Her experience and knowledge will further strengthen the service we offer and her appointment is another important step in the development of our referral team in the South East. Attracting the highest calibre talent is important to CVS because we want to build a referral team, whose members are not only clinically excellent but who also possess first rate communication and inter-personal skills."
Sheila said: "I am excited to be joining the CVS specialist team and look forward to working with like-minded colleagues who are passionate and dedicated to providing the highest level of patient care and client communication. I am delighted to be able to offer a specialist internal medicine service in both feline and canine medicine and look forward to offering a comprehensive service to CVS clients and expanding the internal medicine service further in the future."
Sheila graduated from the Royal Veterinary College in 1998 and spent five years in small animal practice before undertaking an FAB Residency in Feline Medicine at the University of Bristol.
Shortly after her residency, she was appointed Head of Small Animal Medicine and the Feline Centre at the Animal Health Trust where she was based for two years before moving to a major veterinary laboratory in December 2009. She recently returned to the University of Bristol as a teaching fellow in feline medicine.
Sheila acquired her ECVIM Diploma in Internal Medicine in September 2010 and is a Recognised European Veterinary Specialist in Internal Medicine. She became an RCVS Recognised Specialist in Feline Medicine in March 2012 and enjoys all aspects of feline medicine with a specialist interest in feline renal and ureteric disease. She is a member of the ICC Feline Expert Panel and an editorial board member for the Journal of Feline Medicine and Surgery.
Hill's has launched VetEssentials NeuteredCat, a low fat diet for the 90% of UK cats that are estimated to have been neutered.
According to the company, neutered cats are over three times more likely to become overweight and/or suffer from urinary problems.
Hill's says that the low fat formulation of NeuteredCat keeps energy density low, and that its unique Weight Management Formula optimises fat metabolism, whilst preserving lean muscle through supplementation with L-carnitine and L-lysine. The company also claims that NeuteredCat helps to maintain urinary health with levels of minerals carefully controlled to generate a target urine pH of 6.2-6.4.
There are a range of educational and marketing resources to support the new product, available from the company's territory managers.
VetEssentials NeuteredCat will replace any orders made for Science Plan Neutered cat over the coming months.
Zoetis, formerly Pfizer Animal Health, has launched Flexi4, a nutritional supplement for horses containing a patented combination of natural plant extracts designed to help maintain joint flexibility and the management of joint pain.
Flexi4 contains a blend of four plant extracts, Curcumin, Yucca schidigera, Salix alba and Boswellia serrata, which the company says have been shown to have anti-inflammatory, anti-pyretic and analgesic properties as follows:
Mary King, Olympic three day eventing team silver medallist, said: "When performing at the highest level it's important that my horses' joints remain flexible and free of pain. Using Flexi4 has made them more resilient to aches and pains during intense training and I am confident when competing that my horses are feeling the benefit of this natural product, helping them to perform at their very best."
Flexi4 is an apple-flavoured gel that is fed as a once daily supplement. It doesn't contain any substances listed as prohibited by the FEI.* For more information, contact your Zoetis Account Manager, call 0845 300 8034 or email customersupportuk@zoetis.com.
References
*FEI prohibited substance list, 2013
The College says this will pave the way for new diagnostic tests for what could be one of the most common causes of pregnancy loss in mares.
The researchers, led by Dr Mandi de Mestre (pictured right), Reader in Reproductive Immunology and Head of the Equine Pregnancy Laboratory at the RVC, collaborated with seven different veterinary practices to gain access to samples from across the UK and Ireland and found that around 20% of the pregnancies lost were aneuploid, which is when a copy of a whole chromosome is either duplicated or lost (similar to Down's).
Charlotte Shilton, RVC PhD, the student who performed the analysis, applied three different genetic approaches to confirm the results.
Work is now underway to identify the underlying cause of these aneuploid pregnancies, with early data from this study suggesting it is most commonly introduced via the egg or sperm. Until now, chromosomal defects such as aneuploidy have only been reported as a rare condition in young horses with developmental disorders.
The researchers say the study explains why the condition is so rare in horses, with most embryos and foetuses possessing this genetic change dying very early in development, as is also observed in human pregnancy. The study highlights the need to reconsider this genetic condition both in pregnancy loss but also for early developmental disorders.
Dr Mandi de Mestre, Reader in Reproductive Immunology at the RVC, said: “Early pregnancy loss remains a very frustrating condition for clinicians to treat as the underlying cause is unknown in around 80% of cases. These findings will allow researchers to develop new diagnostic tests for pregnancy losses, which would offer hope to thousands of owners of breeding mares that suffer this condition.
“A diagnostic test would allow them to make informed decisions on treatment strategies and to advise on whether they should invest in further attempts to breed their mare benefiting both horses and their breeders alike in the future. I would like to thank both the Thoroughbred Breeders Association and our collaborators at Texas A&M University and the participating veterinary surgeons for their support on this project.
Reference
The sessions will be delivered by Andrew Kent, clinical director at Blaise and a small animal internal medicine specialist, Lara Dempsey, head of soft tissue surgery, Jacques Ferrerira, head of anaesthesia, Mike Farrell, head of orthopaedic surgery, and neurology clinician, Emma Suiter (pictured).
The talks will cover:
Client communication will also be covered, together with some orthopaedics for those with an interest in that area.
Andy said: “We’re building an incredible team at Blaise and are very excited at the prospect of sharing the specialist knowledge that our clinicians have with our wider veterinary community.
"Treating liver conditions can be incredibly complex and our educational programme presents an unrivalled opportunity to deep dive into this part of an animal’s body and how best to approach it.”
Tickets are available for £48 from https://www.ivcevidensiareferrals.com/Delivering-the-Best, with all profits going to the charity StreetVet.
Blaise Veterinary Referral Hospital in Longbridge is IVC’s first purpose-built pet hospital and will be open to accept referral patients from November 2023.
www.blaise-referrals.com
http://herbertsyard.com
The Royal College of Veterinary Surgeons has embarked upon the most extensive review of its veterinary nursing qualifications for many years, in order to meet the timetable for Ofqual's implementation of the Qualifications and Credit Framework (QCF) in summer 2010.
The new QCF aims to provide a more user-friendly and flexible system. Under the new arrangements, all qualifications will carry a 'value' in terms of their level and the volume of learning involved. It's a similar system to that used in higher education for a number of years.
The new national awards framework means that NVQs as such will disappear and the process of review opens up the whole qualification structure, allowing for the creation of a more flexible system to suit better the needs of the veterinary nursing profession and employers.
Head of Veterinary Nursing, Libby Earle said: "Future options include potentially placing more of the responsibility for education and basic skills on the colleges, leaving practices to concentrate on providing quality mentorship and work experience, with less emphasis on assessment.
"Consideration will also be given to providing part of VN training and education within full-time further education, which is possible now that the lower age limit for VN students has been dropped."
The College is keen to hear the views of those involved with the delivery of training and employers of qualified nurses. A consultation letter has been sent to those involved and topics on which views are sought include the range and level of knowledge and skills delivered by the current awards, the impact of training on employers of student VNs, meeting the increased demand for qualified VNs, and providing VNs for mixed or equine practices.
Over the summer, evidence-gathering meetings will be held at the RCVS to explore the issues in more depth. Anyone who has not been sent a formal consultation letter and who would like to contribute is very welcome to submit their views. Please visit www.rcvs.org.uk/vnawardsreview for the consultation papers. Comments should be submitted by 30 June 2009.
The review of the RCVS awards will take place alongside Lantra's review of the National Occupational Standards (NOS) for VNs: the NOS describe what a person needs to do, know and understand in their job to carry out their role in a consistent and competent way.
At the meeting, which took place last Thursday, Council members were asked to decide how to proceed with three specific proposals on reforming the disciplinary system:
Acknowledging some of the concerns that have been raised about changing the standard of proof, RCVS Registrar Eleanor Ferguson said: “The RCVS is now one of just a few regulators that still uses the criminal standard of proof in determining the facts of a case. We have sought these changes as part of our ongoing aim to develop a compassionate and forward-looking disciplinary system with the protection of the public absolutely at its heart, whilst also acknowledging the huge toll the process takes on the mental health of veterinary professionals.
"Research that we carried out into the impact of changing the standard of proof indicated that it would not lead to a major increase in cases being referred from the Preliminary Investigation Committee to the Disciplinary Committee. Importantly the number is likely to be very low because the standard of proof only applies to proving the facts of a case; the judgement as to whether proven facts amount to serious professional misconduct will follow the same process as at present.
"We estimated that during 2019, there could have been just two more cases brought to DC under a altered standard of proof, with an additional three cases that were borderline but probably wouldn’t have proceeded any further. Conversely, we also estimated that three cases that did go to DC during 2019 would probably not have done, had the ‘Charter Case Committee’ option been available.
"Ultimately, the aim of the RCVS in regulating the veterinary professions is to protect the public and animal welfare as well as upholding the reputation of the professions. We believe these changes will better achieve that aim."
The consultation on whether to change the standard of proof as well as to introduce the Charter Case Protocol and ‘mini-PICs’ is now planned for later this year.
Further information about the proposals, including some of the arguments for and against changing the standard of proof, can be found in the papers for RCVS Council at: www.rcvs.org.uk/who-we-are/rcvs-council/council-meetings/4-june-2020/ (pages 70-97).
The Veterinary Marketing Association has announced details of a new award for public relations, open to veterinary practices and companies.
The VMA says this award is to recognise the value that media and public relations can add to the marketing mix. It will be awarded to the company or veterinary practice that has delivered the most innovative PR campaign during 2011, as judged by a panel of industry professionals.
Organiser Claire Edmunds said: "The VMA Awards has become a coveted event for those involved in the animal health industry to showcase their marketing achievements. A range of categories has evolved since the awards began over 20 years ago, for marketing, creative communication and new media campaigns. However, we felt that an award for PR was required to complete the marketing mix".
Jane Manning from award sponsor Splash Marketing & Communications said: "We felt it was time to give the opportunity for those involved in PR to obtain the recognition they deserve alongside their creative colleagues.
"An effective PR campaign can be a highly influential marketing tool, so it's great news that the VMA has added this new award category. We hope that companies and agencies serving the animal health sector will embrace this new opportunity to showcase their creativity and hard work".
The award is for the most innovative PR initiative published during the year. This can be a single 'one-off' event or article, or a sustained campaign over a given period. The winner and two highly commended entries will be awarded at the VMA Awards on Friday 9th March 2012 at Shakespeare's UnderGlobe Theatre, London.
Further information on the awards and ticket application forms are available at the VMA's website - http://www.vma.org.uk/ or by calling 0844 561 6157. The deadline for entries is Friday 27th January 2012.
Bringing together people working at the cutting edge of small animal and equine osteoarthritis treatment with the companies driving technology, supplies and services, the Veterinary Osteoarthritis Congress is open to both VOA members and non-members, including veterinary surgeons, nurses, physiotherapists and others engaged in hydrotherapy and rehabilitation.
Day 1 has two small animal streams – session headings include ‘Managing OA’ and ‘Dealing with chronic pain’; and an equine stream looking at ‘Multidisciplinary management of OA’, ‘OA treatment options’ and ‘Unusual presentations’.
On day 2, ‘Biomodulation in OA’, ‘Working dogs’, ‘Mobility clinic’, and ‘Feline OA focus’ will run alongside sessions on ‘Rehab in action’, ‘Surgery in OA’ and ‘Dietary supplements’.
There’ll also be case presentations and interactive sessions on both days, with demonstrations and lectures from some of the leading firms.
Seven sessions in each stream offers two days of CPD.
After the first day’s sessions there’ll be a happy hour followed by a gala dinner in the Kings Hall. The event is being sponsored by Animalcare (Platinum), TVM UK and the Canine Hydrotherapy Association (Gold) with more to be announced soon.
Professor Stuart Carmichael, co-founder and director of the VOA, said: “Exciting developments are happening in veterinary OA, so we felt now is the right time to put this event on.
"There’s nothing specialist about osteoarthritis treatment and management: every small animal and equine practice deals with OA every day.
“There’s a real need and enthusiasm for bringing the latest thinking to as wide an audience as possible, so VOACON offers sessions for all members of the practice, whatever their interest is, along with rehab and physio teams.
"It’s actually been pretty difficult fitting everything in, but we’re confident we’ve got a great programme offering real, practical CPD that will benefit practices, their clients and their patients.”
Delegate rates for VOA members are:
Non-members (who can join the VOA when booking to qualify for members’ rates):
Rates include a hot buffet lunch, congress book and CPD certification.
To book or to download the programme, visit www.vet-oa.com/voacon.
VetCell Bioscience has become the first UK-based stem cell centre to be authorised under the Veterinary Medicines Regulations.
Following a rigorous series of inspections and reports by Good Manufacturing Practice (GMP) Inspectors VetCell, in conjunction with their UK laboratory partner Biobest, were officially authorised as an equine stem cell centre on 1 October 2009.
David Mountford, Chief Operating Officer of VetCell Bioscience said: "To have received formal authorisation so swiftly reflects the high standard of our operation and our ability to lead the field in the increasingly competitive sector of stem cell technology."
Stem cell therapy involves implanting millions of the animal's own stem cells and autologous growth factors directly into the injured tendon or ligament. The service VetCell Bioscience offers is the collection, storage, processing and supply of stem cells suitable for administration back into the donor animal.
According to the company, there is considerable interest from the human sector and studies in human medicine, for the treatment of Achilles tendinopathies, could begin as early as next year.
Royal Canin is launching a new packaging format for its range of feline wet diets.
The company says the launch comes in response to research showing that more than three-quarters of pet owners (76%1) feed their cats wet food and almost half of wet cat products sold are in a canned format (48%2).
The current alutray packaging will be replaced by 195g cans, which Royal Canin says are easier to use and store, and which clients believe to be better value for money than other packaging formats.
The new cans will contain the same recipes as before, with the same balance of nutrients in each wet diet. They will consist of a loaf or mousse, providing a complementary texture to the chunks in gravy found in the equivalent pouched diets.
Royal Canin is also highlighting the benefits for veterinary practices: The cans are designed to provide greater clarity of display and on-shelf presence. They are also easier to stack for storage, and they meet an established demand.
Ian Williams, one of Royal Canin's small animal vets, said: "We believe the new packaging is an improvement on our established and popular range of wet Veterinary Diets for cats. The range is extensive which allows owners to follow a vet's nutritional recommendations without changing their pets' feeding habits, an excellent way to increase compliance."
The new canned format will be phased in as stocks are replenished, with the following cans being added to the Royal Canin range of wet feline foods: a new Renal and Urinary S/O can, joining the existing Recovery can within the range of Veterinary Diets; and a new Paediatric Weaning can within the Veterinary Care Nutrition range.
For more information about Royal Canin and the diets, visit www.royalcanin.co.uk.
In particular, the association says it is looking for people with expertise in the following areas:
VMG President Rich Casey (pictured right) said: “During the last two years alone, we have launched a new suite of ILM-accredited Award in Veterinary Leadership and Management (AVLM) qualifications, together with our evidence-based Leadership Standards Framework.
"We have also announced our intent to support the specific needs of our members more closely through our own congress and other initiatives, as well as helping to guide the wider veterinary profession through the challenges and opportunities that lie ahead.
“We’re proud of what we have achieved so far but we have much more to do.
'We are looking for several new directors with specific skills to help us offer the highest level of support we can to our members in 2023 and beyond.”
The deadline for applications is 3 October 2022.
https://vetmg.com/vmg-new-director-search
The 10 minute survey seeks to capture the current level of understanding and feelings around the deployment of AI tools across the veterinary industry.
VetCT says the purpose of the survey is to start some discussion and identify areas where training and support could help veterinary practitioners.
Julien Labruyère, Chief Innovation Officer at VetCT (pictured), said: “AI is here to stay and will increasingly become part of all aspects of veterinary medicine.
"Indeed, it’s vital to help us solve some of the workforce pressures the profession is facing globally.
"We will increasingly be using the outputs of AI tools to inform our clinical decisions, and yet the mechanisms and algorithms can be something of a black box of mystery.
“We want to understand the needs of clinicians in understanding how to apply AI safely, effectively and with confidence to support good clinical practice and ultimately, improve animal welfare.
"The results will be published and freely accessible.
"Our hope is to encourage a collaborative effort to support veterinary teams with embracing the full potential of AI, yet also providing the safeguards and education to the clinicians applying this technology to their patients.”
The survey is here: https://bit.ly/VetCT_AI_Survey.
Animalcare has launched a new broad spectrum fluoroquinolone antimicrobial (Enrofloxacin) which the company says is highly effective in the treatment of a wide range of conditions and easy to inject, with excellent tissue penetration.
Enrocare solution for injection is presented in three strengths: A 25mg/ml (2.5%) injection for dogs, cats and exotic animals including reptiles, small mammals and avian species. The 50mg/ml (5%) injection is licensed for use in cattle, pigs, dogs and cats, whilst the 100mg/ml (10%) injection is licensed for cattle and pigs. In the case of dogs and cats a single daily dose is needed.
Animalcare says it has priced Enrocare competitively. In addition, the range has been launched with three offers: "Buy one get one free on the 50 and 100mg/ml" and "Buy two get one free offer" on the 25mg/ml pack size. These offers will last for four months until the end of September.
In cattle, Enrocare 50mg/ml, given by the subcutaneous route, is licensed for respiratory disease of bacterial or mycoplasmal origin and the 100mg/ml strength is licenced for both respiratory disease and E.coli mastitis (the latter given by slow intravenous injection). According to Animalcare, its low dose volume makes it particularly suitable for the treatment of respiratory disease in calves. In pigs >25kg Enrocare is licensed for the treatment of the respiratory and alimentary tract diseases of bacterial or mycoplasmal origin and multi-factorial diseases such as atrophic rhinitis and enzootic pneumonia.
Tony Liepman, Animalcare Market Manager said: "The recent successful launch of Cephacare flavour raised Animalcare's profile as a supplier of more up-to-date antibiotics and this is our latest addition which offers excellent efficacy at an attractive price."
Trinity Vet Centre has launched an Android version of its iPhone / iPad app: Veterinary Care of Exotic Pets.
Designed for veterinary surgeons, veterinary students and veterinary nurses, the app gives the viewer an interactive experience in the care of exotic animals and includes videos of blood sampling, images of sex determination and images of common conditions including avian radiographic interpretation.
The app also contains formularies for all the commonly encountered exotic species, lists of commonly seen conditions (and their treatment) and biological data all at the touch of the screen. In addition the latest update for the iPhone / iPad features new sections on birds of prey and poultry which will also be available on the android version.
The app's developer, zoological medicine certificate holder Mark Rowland said: "This app is here to help vets offer the same high level of service offered to dog and cat clients to exotic animals which are becoming even more common. Data such as gestation periods and drug doses for exotics can easily be accessed. The videos are there to show in more detail how to blood sample exotics from Guinea Pigs to Tortoises"
The app is available from your iPhone or Android App store, priced at £7.99
'Period prevalence and mortality rates associated with hypocholesterolaemia in dogs and cats: 1,375 cases1' determined the period prevalence of hypocholesterolaemia and the associated mortality rates in dogs and cats at the Veterinary Medical Teaching Hospital, University of California, Davis.
The medical records of cats and dogs presenting to the hospital from 1st September 2011 to 30th August 2016 were retrospectively reviewed to identify all animals that had at least 1 cholesterol measurement; a total of 16,977 dogs and 3,788 cats were identified. Patient signalment and clinical information were collated from the medical records, including the primary disease processes in patients with moderate to severe hypocholesterolaemia. The period prevalence and mortality rate of hypocholesterolaemia were calculated.
The period prevalence of hypocholesterolaemia was 7.0% in dogs and 4.7% in cats. The mortality rate of hypocholesteraemic dogs and cats was 12% in both species, which was significantly higher than that of animals with normal serum cholesterol.
Steven Epstein, corresponding author for the paper, said: 'The odds of death in dogs and cats with hypocholesterolaemia were 3.2 and 2.5 times higher than in those with normocholesterolaemia respectively. Furthermore, there was a significant linear trend towards higher mortality in association with more severe hypocholesterolaemia in both species.
'Disease of the hepatic, gastrointestinal and lymphoreticular systems were most commonly associated with hypocholesterolaemia, and infectious and neoplastic disease were the most commonly associated pathophysiological processes in both species. In dogs with neoplasia, lymphoma was over-represented.'
Nicola Di Girolamo, Editor of JSAP said: 'These findings suggest that low cholesterol levels are associated with mortality in canine and feline patients. It is not clear whether hypocholesterolaemia is simply a marker for disease severity, or if it has active physiological effects contributing to poor outcomes. At this stage, it seems indicated to enhance intensity of diagnostic effort and therapy for affected animals.'
The full article can be found in the November issue of the Journal of Small Animal Practice which is free for BSAVA members. It can also be read online here: https://www.onlinelibrary.wiley.com/doi/10.1111/jsap.13204
Feliway Help! comes as a starter pack with a pheromone cartridge which lasts seven days and covers 50m2.
The cartridge is inserted into a diffuser which is plugged into an electrical socket, two days before the stressful event.
Ceva says that 83% of cat owners saw an improvement in their cat’s signs of stress after using Feliway Help!1.
The company adds that the Feliway Help! is particularly useful for clients of those practices which Feliway on the premises, with Feliway helping keep the cat calm at the practice, and Feliway Help! taking over when they return home.
Sarah Heath BVSc PgCertVE DipECAWBM(BM) CCAB FRCVS, an RCVS and EBVS European Veterinary Specialist in Behavioural Medicine and Certified Clinical Animal Behaviourist, said: “Cats can find the veterinary visit challenging and when they go home they can sometimes find it hard to settle.
"Feliway Help! can be very beneficial in easing the transition between home and the practice.
"This can be particularly helpful when cats have had a stay in hospital.”
For more information, visit www.feliway.com/uk, call the Ceva Animal Health head office on 01494 781510 or email cevauk@ceva.com.
The refreshed packaging keeps the same colour scheme, but the graphics indicating the product uses stand out better.
The company has also added an area on the side of the carton for owners to note the date each dose is given.
What can I say, it's a slow news day.
Idexx Laboratories has launched a new renal function test, Idexx SDMA, which the company says can detect chronic kidney disease (CKD) in dogs or cats months or even years earlier than traditional methods.
The test is based on a new renal biomarker - symmetric dimethylarginine (SDMA) - and is the result of collaboration with a number of global experts.
Simon Wootton, UK CAG Marketing Manager at Idexx said: "The high sensitivity of this marker for detecting CKD will allow vets to diagnose the disease a lot sooner than has been previously possible. Identifying the disease earlier will give vets more time to intervene and prescribe an appropriate course of action."
The company says that the Idexx SDMA test can identify renal disease in dogs up to nine months earlier than previous methods, while in cats the detection time can be up to 17 months earlier.
Dr Martha Cannon, BA VetMB DSAM(fel) RCVS Recognised Specialist in Feline Medicine of the Oxford Cat Clinic, said: "The launch of SDMA testing is very exciting. It offers the prospect of identifying chronic kidney disease at an earlier stage, which should mean we can treat it more effectively and allow us to maintain cats in the asymptomatic phase. This can improve longevity, but more importantly could help maintain a better quality of life for longer.
"SDMA is also unaffected by muscle loss, which will allow us to assess the true extent of CKD in our elderly and underweight cats. This will lead to improved treatment choices, better quality of life and more peace of mind for owners."
The value of the new test has been validated by the adoption of SDMA into the International Renal Interest Society (IRIS) guidelines as a biomarker for the early detection of CKD.
Jonathan W. Ayers, President and Chief Executive Officer of Idexx Laboratories, said: "Idexx SDMA is a result of our commitment to lead the industry in sustained research investments that serve to advance veterinary medicine. It represents a significant achievement in veterinary diagnostics. Hospitals in the USA already using Idexx SDMA have told us that it has transformed the way renal disease is diagnosed and treated."
Idexx SDMA is available to UK and Ireland reference laboratory customers now. Further information is available at www.idexxsdma.com.
Video shows Sylvia Conway MRCVS, UK Medical Affairs Consultant at Idexx, talking about the new test (can also be viewed here).
In 2019, Jennifer Dykes won the ‘All creatures great and small’ category with her picturesque image of a misty UK mountainside and flock of sheep, entitled ‘Conversations at Dawn’.
This year’s award is split into three categories which focus on images that capture the human-animal bond in day-to-day veterinary work, as well as photos of pets or wildlife taken outside of the working environment.
Submissions for each category can be taken on a phone or a high-spec camera, and should take into account responsible animal interaction, and positive animal health and welfare.
The three categories are:
The winner or each category will get £250 worth of John Lewis vouchers and the plan is for the winning images, along with the highly commended entries, to be displayed at BVA Live on 24 – 25 June 2021.
BVA President, James Russell said: “The BVA Veterinary Photographer of the Year Award is something that we all look forward to, and the incredible array of eye-catching photos taken by people from across the veterinary community never ceases to impress me.
“In view of the current circumstances, we have introduced a new category: ‘A vet’s life in lockdown’, which we hope will produce some interesting documentation of how the profession has fared against a very challenging backdrop, like no other.
“Whether you’re a semi-professional photographer or a casual snapper, we encourage you to enter and showcase your daily interactions with animals either at work or play, or your skill at capturing wildlife at its most beautiful, even if it is in your back garden, or on the windowsill.”
The competition is open to all current BVA members. Membership must be active at the time of entering. It will be judged by BVA officers among others. Entries will close on 8 March 2021 and winners will be announced in April.
For more information and to submit your entry, visit: https://www.bva.co.uk/membership/photo-competition/.